Chapter 2 Summary and Highlights
- Market Outlook
- Highlights of the Neurology Devices Market
Chapter 3 Market Background and Definitions
- Overview
- Neurology Devices
- Neurosurgical Devices
- Neuromodulation Devices
- Neurovascular Devices
- Neurodiagnostic Equipment
- Diseases Background
- Stroke
- Parkinson’s Disease
- Alzheimer’s Disease
- Epilepsy and Seizures
- Carotid Artery Disease
- Cerebral Aneurysms
- Tremors
- Multiple Sclerosis
- Depression
Chapter 5 Market Breakdown by Product Type
- Overview
- Neurosurgical Devices
- Neuromodulation Devices
- Neurovascular Devices
- Neurodiagnostic Devices
Chapter 6 Market Breakdown by Region
- Overview
- North America
- Latin America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 7 Emerging Trends/Technologies in the Neurology Devices Market
- Overview
- AI in Neurology
- Wearable Neurology Devices
- Precision Radiotherapy in Neurology
- Stereotactic Radiosurgery
- Stereotactic Body Radiation Therapy
- Brain-Computer Interfaces (BCIs)
Chapter 8 Sustainability in Neurology Devices Market: An ESG Perspective
- Overview
- Introduction to ESG
- Environmental Factors
- Social Factors
- Governance Factors
- Neurology Devices Market ESG Performance Analysis by Company
- Consumer Attitude Towards ESG in the Neurology Devices Market
- Conclusion
Chapter 9 Pipeline Analysis
Chapter 10 Competitive Landscape
- Industry Scenario
- Company Shares
Chapter 11 Company Profiles
- ABBOTT
- AXONICS INC.
- BOSTON SCIENTIFIC CORP.
- B. BRAUN SE
- DANAHER CORP.
- ELEKTA
- GE HEALTHCARE
- INTEGRA LIFESCIENCES
- JOHNSON & JOHNSON SERVICES INC.
- KONINKLIJKE PHILIPS N.V.
- LIVANOVA PLC
- MEDTRONIC PLC
- NATUS MEDICAL INC.
- NEVRO CORP.
- NIHON KOHDEN CORP.
- PENUMBRA INC.
- STRYKER CORP.
- SIEMENS HEALTHCARE GMBH
- TERUMO MEDICAL CORP.
List of Tables
Summary Table: Global Market for Neurology Devices, by Product Type, Through 2028
Table 1: Global Population, Aged 60 Years and Older, 2017-2050
Table 2: Prevalent Cases of Brain and Central Nervous System Cancer, by Country, 2015-2030
Table 3: Prevalent Cases of Parkinson’s Disease, by Country, 2015-2030
Table 4: Prevalent Cases of Ischemic Stroke, by Country, 2015-2030
Table 5: Prevalent Cases of Idiopathic Epilepsy, by Country, 2015-2030
Table 6: Prevalent Cases of Alzheimer’s and Dementia, by Country, 2015-2030
Table 7: Global Market for Neurology Devices, by Product Type, Through 2028
Table 8: Global Market for Neurosurgical Devices, by Region, Through 2028
Table 9: Global Market for Neuromodulation Devices, by Region, Through 2028
Table 10: Global Market for Neurovascular Devices, by Region, Through 2028
Table 11: Global Market for Neurodiagnostic Devices, by Region, Through 2028
Table 12: Global Market for Neurology Devices, by Region, Through 2028
Table 13: North American Market for Neurology Devices, by Country, Through 2028
Table 14: Latin American Market for Neurology Devices, by Country, Through 2028
Table 15: European Market for Neurology Devices, by Country, Through 2028
Table 16: Asia-Pacific Market for Neurology Devices, by Country, Through 2028
Table 17: RoW Market for Neurology Devices, Through 2028
Table 18: Medtronic: ESG Performance
Table 19: Medtronic: ESG Goals
Table 20: Abbott: ESG Performance
Table 21: Terumo: ESG Performance
Table 22: Selected Neuromodulation Devices in Clinical Trials, as of 2023
Table 23: Abbott: Neurostimulation Product Portfolio
Table 24: Axonics Inc.: News, 2023
Table 25: Axonics Inc.: Product Portfolio
Table 26: Boston Scientific Corp.: News, 2023
Table 27: Boston Scientific Corp.: Product Portfolio
Table 28: B. Braun Se: Neurodevice Product Portfolio
Table 29: Danaher Corp.: Company Financials, 2022
Table 30: Danaher Corp.: Product Portfolio
Table 31: Elekta: Product Portfolio
Table 32: Natus Medical Inc.: Product Portfolio
Table 33: Nihon Kohden Corp.: Product Portfolio
Table 34: Penumbra Inc: Neurovascular Product Portfolio
Table 35: Stryker: Business Segments
Table 36: Siemens Healthineers: Product Portfolio
Table 37: Acronyms Used in this Report
List of Figures
Summary Figure A: Global Market for Neurology Devices, by Product Type, 2020-2028
Summary Figure B: Global Market Shares of Neurology Devices, by Product Type, 2022
Figure 1: Global Market for Neurology Devices, by Product Type, 2020-2028
Figure 2: Global Market Shares of Neurology Devices, by Product Type, 2022
Figure 3: Global Market for Neurosurgical Devices, by Region, 2020-2028
Figure 4: Global Market for Neuromodulation Devices, by Region, 2020-2028
Figure 5: Global Market for Neurovascular Devices, by Region, 2020-2028
Figure 6: Global Market for Neurodiagnostic Devices, by Region, 2020-2028
Figure 7: Global Market Shares of Neurology Devices, by Region, 2022
Figure 8: North American Market Shares of Neurology Devices, by Country, 2022
Figure 9: Latin American Market Shares of Neurology Devices, by Country, 2022
Figure 10: European Market Shares of Neurology Devices, by Country, 2022
Figure 11: Asia-Pacific Market Shares of Neurology Devices, by Country, 2022
Figure 12: Emerging Trends and Technologies in the Neurology Devices Market
Figure 13: Medtronic: Greenhouse Gas Emissions, 2020-2022
Figure 14: Medtronic: Water Use, 2020-2022
Figure 15: Medtronic: Total Waste Generated, 2020-2022
Figure 16: Global Neurology Devices, Company Share, 2022
Figure 17: Global Neurosurgical Devices, Company Share, 2022
Figure 18: Global Neuromodulation Devices, Company Share, 2022
Figure 19: Global Neurovascular Devices, Company Share, 2022
Figure 20: Global Neurodiagnostic Devices, Company Share, 2022
Figure 21: Abbott: Diagnostics Division, Net Revenue, 2020-2022
Figure 22: Abbott: Market Share, by Business Segment, 2022
Figure 23: Axonics Inc.: Net Revenue, 2020-2022
Figure 24: Axonics Inc.: Market Share, by Business Segment, 2022
Figure 25: Axonics Inc.: Sales Share, by Region, 2022
Figure 26: Boston Scientific Corp.: Net Revenue, 2020-2022
Figure 27: Boston Scientific Corp.: Market Share, by Business Segment, 2022
Figure 28: B. Braun Se: Net Revenue, 2020-2022
Figure 29: Danaher Corp.: Revenue Share, by Business Segment, 2022
Figure 30: Danaher Corp.: Revenue Share, by Region, 2022
Figure 31: Integra LifeSciences: Net Revenue, 2020-2022
Figure 32: Integra LifeSciences: Market Share, by Business Segment, 2022
Figure 33: LivaNova Plc: Neuromodulation Sales Share, by Region, 2022
Figure 34: Nevro Corp.: Net Revenue, 2020-2022
Figure 35: Nevro Corp.: Sales Share, by Region, 2022
Figure 36: Penumbra: Net Revenue, 2020-2022
Figure 37: Penumbra: Neuro Products Revenue, 2020-2022
Figure 38: Stryker: Net Revenue, 2020-2022
Figure 39: Stryker: Market Share, by Business Segment, 2022
Figure 40: Siemens Healthineers: Net Revenue, 2020-2022
Figure 41: Siemens Healthineers: Market Share, by Business Segment, 2022